Sanofi Accelerates Its ‘Carbon Neutral’ Pledge Ahead Of Climate Summit
Sets 2030 Carbon Neutrality Goal
The France-headquartered company has brought forward its carbon neutral goal, making it one of the sector’s most proactive companies.
You may also be interested in...
Sanofi is on a roll thanks to Dupixent and the blockbuster is providing breathing space even when some key pipeline assets are delayed.
Vertex has acquired the full assets to a promising protease-based drug platform from Catalyst, broadening its R&D base once again.
Activist investor All Blue wants to mount a takeover, but the biotech’s board is holding out for encouraging pipeline news to help fight off the bid.